arrow
返回
A

Anthony H. Cincotta

harvard university medical affiliates

33H指数
105论文数
3.2K被引数
收录论文 38
发表时间
Bromocriptine-QR Reduces Elevated Postprandial Cardiometabolic Risk Factors in Type 2 Diabetes Subjects
err2024-06-14
err0
PREAI
errChamarthi, Bindu; Ezrokhi, Michael; Cincotta, Anthony H.
err分享
err收藏
Bromocriptine-QR (BQR) Ameliorates Immunocyte Pro-Oxidative Stress/Pro-inflammatory (POS/PI) and ER Stress Phenotype in T2DM Subjects
err2021-06-01
err0
PREAI
errEzrokhi, Michael; Cincotta, Anthony H.; Cersosimo, Eugenio; Adams, John M., II; Alatrach, Mariam; Agyin, Christina; Triplitt, Curtis L.; Cominos, Nicholas; Defronzo, Ralph A.
err分享
err收藏
Experimental dopaminergic neuron lesion at the area of the biological clock pacemaker, suprachiasmatic nuclei (SCN) induces metabolic syndrome in rats
err2021-01-23
err17
errOAAI
errLuo, Shuqin; Ezrokhi, Michael; Cominos, Nicholas; Tsai, Tsung-Huang; Stoelzel, Carl R.; Trubitsyna, Yelena; Cincotta, Anthony H.
err分享
err收藏
Bromocriptine-OR (BQR) Ameliorates a Pro-oxidative Stress/Proinflammatory (POS/PI) Monocyte Phenotype in Poorly Controlled T2DM Subjects
err2020-06-01
err0
PREAI
errEzrokhi, Michael; Cincotta, Anthony; Cersosimo, Eugenio; Adams, John M., II; Alatrach, Mariam; Agyin, Christina; Triplitt, Curtis L.; Cominos, Nicholas; Defronzo, Ralph A.
err分享
err收藏
Bromocriptine-QR (BQR) Reduces Hypertriglyceridemia (HTG) in Hypertensive Type 2 Diabetes (T2D) Subjects
err2020-06-01
err1
PREAI
errChamarthi, Bindu; Ezrokhi, Michael; Cincotta, Anthony H.
err分享
err收藏
Dopamine D1 plus D2 Receptor Coactivation Ameliorates Metabolic Syndrome (MS) and Nonalcoholic Fatty Liver Disease (NAFLD) in Mice
err2019-06-01
err0
PREAI
errEzrokhi, Michael; Luo, Shuqin; Cominos, Nicholas; Raiche, Benjamin; Gustafson, Melanie; Cincotta, Anthony H.
err分享
err收藏
Bromocriptine-QR (BQR) Therapy Reduces Elevated Sympathetic Nervous System Activity (SNSA) and Oxidative Stress (OS) in Type 2 Diabetes (T2D) Subjects whose Dysglycemia Is Poorly Controlled on GLP-1 Receptor Agonist (GLP-1RA)
err2019-06-01
err0
PREAI
errChamarthi, Bindu; Cersosimo, Eugenio; Adams, John M., II; Alatrach, Mariam; Agyin, Christina; Triplitt, Curtis L.; Ezrokhi, Michael; Luo, Shuqin; Duvallet, Emilie; Cincotta, Anthony H.; Defronzo, Ralph A.
err分享
err收藏
High-Fat Diet Induces Diabetogenic Alteration of Ventromedial Hypothalamus (VMH) Glucose Sensing Neurons That Is Reversed by Circadian-Timed Bromocriptine Treatment
err2018-07-01
err0
PREAI
errStoelzel, Carl; Duvallet, Emilie; Zhang, Yahong; Tsai, Tsung-Huang; Ezrokhi, Michael; Cincotta, Anthony
err分享
err收藏
Silencing of Supramammillary Nucleus (SuMN) Dopaminergic Neuronal Activity Induces the Obese Glucose Intolerant State
err2018-07-01
err0
PREAI
errZhang, Yahong; Tsai, Tsung-Huang; Ezrokhi, Michael; Stoelzel, Carl; Cincotta, Anthony
err分享
err收藏
Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes (vol 33, pg 1503, 2010 )
err2016-09-13
err2
errOAAI
errGaziano, J. Michael; Cincotta, Anthony H.; O'Connor, Christopher M.; Ezrokhi, Michael; Rutty, Dean; Ma, Z. J.; Scranton, Richard E.
err分享
err收藏
Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus
err2015-01-01
err31
errOAAI
errChamarthi, Bindu; Gaziano, J. Michael; Blonde, Lawrence; Vinik, Aaron; Scranton, Richard E.; Ezrokhi, Michael; Rutty, Dean; Cincotta, Anthony H.
err分享
err收藏
Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats
err2014-09-25
err32
errOAAI
errEzrokhi, Michael; Luo, Shuqin; Trubitsyna, Yelena; Cincotta, Anthony H.
err分享
err收藏
EFFECT OF BROMOCRIPTINE-QR ON GLYCEMIC CONTROL IN SUBJECTS WITH UNCONTROLLED HYPERGLYCEMIA ON ONE OR TWO ORAL ANTI-DIABETES AGENTS
err2012-11-01
err33
PREAI
errVinik, Aaron I.; Cincotta, Anthony H.; Scranton, Richard E.; Bohannon, Nancy; Ezrokhi, Michael; Gaziano, J. Michael
err分享
err收藏